Skip to main content
OpenTrials
Completed

NCT Number: NCT01569529

Young Adult Smoker's Treatment Demand

The purpose of this study is to determine whether tailored online advertisements will drive young adult smoker's (18 to 26 years old), who are motivated to quit, to use Internet-based cessation treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute for Health Reseach and Policy, UIC

Chicago, Illinois, 60608, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 30 years old
  • smoke on some days or everyday
  • enrollment in specified online cessation program

Treatment and study plan

Online advertisement

Behavioral

Internet advertisement with messages tailored for young adult smoker's motivated to quit

Primary outcomes

  1. Program Enrollment

    Time frame: 1-month intervals over 7 months

    Rates of enrollment will be calculated as the proportion of visitors who enroll in treatment (e.g., number of enrollments/number of click-throughs from banner ads).

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Collaborators

  • National Cancer Institute (NCI)
  • Truth Initiative
  • University of Iowa

Registry information

Official study title

Increasing Young Adult Smoker's Demand for Internet-based Cessation Treatment

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Apr 3, 2012
Registry last updated
Mar 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.